Solve M.E. & BIO present “Long Covid: What Will it Take to Accelerate Therapeutic Progress?” (pt 1)

Solve M.E. and BIO co-hosted a timely and informative event examining the emerging research in Long Covid and the existing body of data in other post-infection diseases such as ME/CFS. The event was designed to bring biotech into the conversation about Long Covid and other post-infection diseases and was well-attended by industry drug-developer, academic researchers, healthcare providers, patient advocates, and policymakers.